With the growing demand for preventive healthcare and complex manufacturing requirements, many nutraceutical and pharmaceutical companies are expanding their horizons by partnering with a CDMO for both clinical and commercial stage manufacturing. An upsurge in demand for robust processes and integration of state-of-the-art production technologies has become imperative to meet every requirement, irrespective of the industry vertical.
A thrust to bring forth the needed innovation which increases productivity, flexibility, adaptability and effectiveness is gaining momentum throughout the market dynamics today. Hence, it has become imperative to strategically tie-up with CDMO to meet the quality standards, timely deliverability and ROI. This can be dealt by aligning oneself with a partner who is a subject matter expert and has the competency not only to meet but exceed expectations.
Coming to the fore, Tirupati Group is a one-stop-solution provider that has been hand-holding its clients from concept to research to the final product launch. Its internationally standardized manufacturing and R&D capabilities make it a prominent entity to overcome and meet every challenge and expectation of a client, be it compliance, data-integrity, agility, future-readiness or scalability among others.
Furthermore, its state-of-the-art plant and infrastructure has been integrated with cutting edge technology and approaches that adhere to various compliance standards such as cGMP, QMS, GHP, NABL, GLP and DSIR. The competency and experience, Tirupati holds has made it the
most trusted CDMO companies that can live up to the expectation of leading companies across segments.
“First prevention then cures” is what Tirupati believes in. We are the pioneers of Nutraceutical & Herbal CDMO space with a legacy of credibility and market leadership. Hence, the effort that we have put in delivering quality products has bestowed us with numerous awards and recognition,” highlights Dinesh Goyal, Founder & Mentor Tirupati Group.
Offering end-to-end solutions
Tirupati’s unparalleled CRO capabilities also has the track record of developing novel formulations for reputed companies like Abbott, Dr. Reddy’s Laboratories, Cipla, Lupin etc. Tirupati has strengthened its R&D infrastructure for Nutraceutical and Herbal formulations with the recent launch of state-of-the-art Tirupati Innovation Center. Being a vertically integrated organization, Tirupati has uniquely positioned itself to deliver one-stop solutions across every parameter; ideation, conceptualization, development and manufacturing for industries that include pharmaceuticals, nutraceuticals, Ayurveda, sports nutrition and veterinary.
Ashok Goyal, Founder & CEO
Tirupati Group offers products across 20+ Therapeutic Areas through 1100+ SKUs. They have the needed expertise and experience to manufacture almost the entire width and depth of product dosage forms such as Gels, Tablets, Liquid, Powder, Emulsions, Creams and Ointments etc. They have been offering products that cover key TAs such as Analgesic, Diabetes Care, Hepatoprotectives, Laxatives, Antidepressants, Bone Health, Cough and Cold, Gastro Care, Cardioprotective among others.
“We want to further strengthen our leadership position in the Nutraceutical and Herbal space by offering innovative and quality products. Our global footprint is being strengthened by targeted approach towards emerging markets across CIS, MENA, ASEAN, LATAM and AFRICAN sub-continents. Also, we are tying ourselves with global partners to rigorously support the Make-in-India initiatives.
In addition to existing verticals, we are looking forward to expanding our offerings across industries namely, Veterinary, Targeted Nutrition, Pre-& Probiotics. Going forward, we will continuously innovate and invest in novel technology platforms like Nanotechnology & Liposomal technology,” concludes Ashok Goyal, Founder & CEO Tirupati Group.
.jpg "Artificial Intelligence to Revolutionize Advanced Chip Design")
